Treatment strategies for hormone receptor-positive, human epidermal growth factor receptor 2-positive (HR+/HER2+) metastatic breast cancer: A review
Article in Frontiers in Oncology (December 2022)
The most recent citing publications are shown below. View all 27 publications that cite this research output on Dimensions.
Relapse-free survival in Sudanese women with non-metastatic breast cancer
Article in Global Epidemiology (December 2022)
Characterization of 940 Chinese patients with triple-positive breast cancer by clinicopathological and treatment outcomes
Preprint in Research Square (October 2022)